Literature DB >> 23011502

High prevalence of late diagnosis of HIV in Mexico during the HAART era.

Brenda Crabtree-Ramírez1, Yanink Caro-Vega, Francisco Belaunzarán-Zamudio, Juan Sierra-Madero.   

Abstract

OBJECTIVE: To evaluate the prevalence of late HIV diagnosis (CD4<200 cell/mm³) in an HIV clinic in Mexico City between 2001-2008, to assess changes in this prevalence across the study period, and to determine the risk factors associated to late testing (LT).
MATERIALS AND METHODS: Cross-sectional analysis including all patients recently diagnosed as HIV. We estimated the proportion of LT patients and compared demographic characteristics between those and all other. We determine the risk factors associated to LT using logistic regression methods.
RESULTS: Sixty one percent of LT patients present when are diagnosed for the first time. The prevalence did not decrease between 2001 and 2008 (p=0.37). Older age (OR: 2.4; 95%CI 1.2-4.7), unemployment (OR: 1.75; 95%CI 1.12-2.75) and less than nine years of education (OR: 2.44; 95%CI 1.37-4.33) were independently associated to LT, in a multivariate analysis.
CONCLUSION: LT has high prevalence in Mexico, this impact on antiretroviral effectiveness and perhaps on HIV transmission. Policies for HIV-prevention in Mexico need to be modified to reduce LT prevalence including more aggressive strategies of testing.

Entities:  

Mesh:

Year:  2012        PMID: 23011502     DOI: 10.1590/s0036-36342012000500007

Source DB:  PubMed          Journal:  Salud Publica Mex        ISSN: 0036-3634


  14 in total

1.  Evaluating the care cascade after antiretroviral therapy initiation in Latin America.

Authors:  Marcelo J Wolff; Claudia P Cortes; Fernando A Mejìa; Denis Padgett; Pablo Belaunzarán-Zamudio; Beatriz Grinsztejn; Mark J Giganti; Catherine C McGowan; Peter F Rebeiro
Journal:  Int J STD AIDS       Date:  2017-06-15       Impact factor: 1.359

2.  HIV Drug Therapy in the Americas 16-18 April 2015, Mexico City, Mexico.

Authors: 
Journal:  J Int AIDS Soc       Date:  2015-04-16       Impact factor: 5.396

3.  Late Presentation and Missed Opportunities for HIV Diagnosis in Guatemala.

Authors:  Johanna Meléndez; Samuel W Reinhardt; Jane A O'Halloran; Andrej Spec; Andrea Alonzo Cordon; William G Powderly; Carlos Mejia Villatoro
Journal:  AIDS Behav       Date:  2019-04

4.  HIV testing practices and the potential role of HIV self-testing among men who have sex with men in Mexico.

Authors:  Catherine E Oldenburg; Katie B Biello; Amaya G Perez-Brumer; Joshua Rosenberger; David S Novak; Kenneth H Mayer; Matthew J Mimiaga
Journal:  Int J STD AIDS       Date:  2016-07-11       Impact factor: 1.359

5.  Preventing HIV Transmission Among Partners of HIV-Positive Male Sex Workers in Mexico City: A Modeling Study.

Authors:  João Filipe G Monteiro; Brandon D L Marshall; Daniel Escudero; Sandra G Sosa-Rubí; Andrea González; Timothy Flanigan; Don Operario; Kenneth H Mayer; Mark N Lurie; Omar Galárraga
Journal:  AIDS Behav       Date:  2015-09

6.  The Population Impact of Late Presentation With Advanced HIV Disease and Delayed Antiretroviral Therapy in Adults Receiving HIV Care in Latin America.

Authors:  Pablo F Belaunzarán-Zamudio; Yanink N Caro-Vega; Bryan E Shepherd; Peter F Rebeiro; Brenda E Crabtree-Ramírez; Claudia P Cortes; Beatriz Grinsztejn; Eduardo Gotuzzo; Fernando Mejia; Denis Padgett; Jean W Pape; Vanessa Rouzier; Valdilea Veloso; Sandra Wagner Cardoso; Catherine C McGowan; Juan G Sierra-Madero
Journal:  Am J Epidemiol       Date:  2020-06-01       Impact factor: 4.897

7.  Identifying opportunities to increase HIV testing among mexican migrants: a call to step up efforts in health care and detention settings.

Authors:  Ana P Martínez-Donate; Maria Gudelia Rangel; Natalie Rhoads; Xiao Zhang; Melbourne Hovell; Carlos Magis-Rodriguez; Eduardo González-Fagoaga
Journal:  PLoS One       Date:  2015-04-10       Impact factor: 3.240

8.  Estimating the Impact of Earlier ART Initiation and Increased Testing Coverage on HIV Transmission among Men Who Have Sex with Men in Mexico using a Mathematical Model.

Authors:  Yanink Caro-Vega; Carlos del Rio; Viviane Dias Lima; Malaquias Lopez-Cervantes; Brenda Crabtree-Ramirez; Sergio Bautista-Arredondo; M Arantxa Colchero; Juan Sierra-Madero
Journal:  PLoS One       Date:  2015-08-24       Impact factor: 3.240

9.  Is the HIV epidemic stable among MSM in Mexico? HIV prevalence and risk behavior results from a nationally representative survey among men who have sex with men.

Authors:  Sergio Bautista-Arredondo; M Arantxa Colchero; Martín Romero; Carlos J Conde-Glez; Sandra G Sosa-Rubí
Journal:  PLoS One       Date:  2013-09-05       Impact factor: 3.240

10.  CD4 Counts at Entry to HIV Care in Mexico for Patients under the "Universal Antiretroviral Treatment Program for the Uninsured Population," 2007-2014.

Authors:  Alfonso C Hernández-Romieu; Carlos del Rio; Juan Eugenio Hernández-Ávila; Hugo Lopez-Gatell; José Antonio Izazola-Licea; Patricia Uribe Zúñiga; Mauricio Hernández-Ávila
Journal:  PLoS One       Date:  2016-03-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.